The impact of Aggrus/podoplanin on platelet aggregation and tumour metastasis

Journal of Biochemistry

Volumn 152, Issue 5, 2012, Pages 407-413

  Fujita, Naoya ^a   Takagi, Satoshi ^a  

^a CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

Aggrus; CLEC 2; platelets; podoplanin; tumour metastasis

Indexed keywords

ANGIOGENIC FACTOR; C TYPE LECTIN LIKE RECEPTOR 2; GROWTH FACTOR; LECTIN RECEPTOR; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PODOPLANIN; THROMBOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; BLOOD CLOTTING; CARCINOGENESIS; CELL SURFACE; GLIOBLASTOMA; HOMEOSTASIS; HUMAN; INFLAMMATION; MALIGNANT NEOPLASTIC DISEASE; MESOTHELIOMA; METASTASIS; NONHUMAN; OSTEOSARCOMA; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVIEW; SQUAMOUS CELL CARCINOMA; TANDEM REPEAT; THROMBOCYTE AGGREGATION; TISSUE REGENERATION; TUMOR GROWTH;

ANIMALS; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; NEOPLASM METASTASIS; PLATELET AGGREGATION;

EID: 84868553323     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvs108     Document Type: Review

References (50)

1. Tsuruo, T. and Fujita, N. (2008) Platelet aggregation in the formation of tumor metastasis. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 84, 189-198
2. Fidler, I.J. (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 3, 453-458
3. Fidler, I.J. (1970) Metastasis: guantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2'-deoxyuridine. J. Natl. Cancer Inst. 45, 773-782
4. Buergy, D., Wenz, F., Groden, C, and Brockmann, M.A. (2012) Tumor-platelet interaction in solid tumors. Int. J. Cancer 130, 2747-2760
5. Ho-Tin-Noe, B., Goerge, T., and Wagner, D.D. (2009) Platelets: guardians of tumor vasculature. Cancer Res. 69, 5623-5626
6. Blom, J.W., Vanderschoot, J.P., Oostindier, M.J., Osanto, S., van der Meer, F.J., and Rosendaal, F.R. (2006) Incidence of venous thrombosis in a large cohort of 66, 329 cancer patients: results of a record linkage study. J. Thromb. Haemost. 4, 529-535
7. Klerk, C.P., Smorenburg, S.M., Otten, H.M., Lensing, A.W., Prins, M.H., Piovella, F., Prandoni, P., Bos, M.M., Richel, D.J., van Tienhoven, G, and Buller, H.R. (2005) The effect of low molecular weight heparin on survival in patients with advanced malignancy. J. Clin. Oncol. 23, 2130-2135
8. Erpenbeck, L. and Schon, M.P. (2010) Deadly allies: the fatal interplay between platelets and metastasizing cancer cells. Blood 115, 3427-3436
9. Oleksowicz, L., Mrowiec, Z., Schwartz, E., Khorshidi, M., Dutcher, J.P., and Puszkin, E. (1995) Characterization of tumor-induced platelet aggregation: the role of immunorelated GPIb and GPIIb/IIIa expression by MCF-7 breast cancer cells. Thromb. Res. 79, 261-274
10. Morimoto, K., Satoh-Yamaguchi, K., Hamaguchi, A., Inoue, Y., Takeuchi, M., Okada, M., Ikeda, W., Takai, Y., and Imai, T. (2008) Interaction of cancer cells with platelets mediated by Necl-5/poliovirus receptor enhances cancer cell metastasis to the lungs. Oncogene 27, 264-273
11. Nakamori, S., Kameyama, M., Imaoka, S., Furukawa, H., Ishikawa, O., Sasaki, Y., Kabuto, T., Iwanaga, T., Matsushita, Y., and Irimura, T. (1993) Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res. 53, 3632-3637
12. Mannori, G, Crottet, P., Cecconi, O., Hanasaki, K., Aruffo, A., Nelson, R.M., Varki, A., and Bevilacqua, M.P. (1995) Differential colon cancer cell adhesion to E-, P-, and L-selectin: role of mucin-type glycoproteins. Cancer Res. 55, 4425-4431
13. Felding-Habermann, B., Habermann, R., Saldivar, E., and Ruggeri, Z.M. (1996) Role of beta3 integrins in melanoma cell adhesion to activated platelets under flow. J. Biol. Chem. 271, 5892-5900
14. Corbett, T.H., Griswold, D.P. Jr, Roberts, B.J., Peckham, J.C., and Schabel, F.M. Jr. (1975) Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res. 35, 2434-2439
15. Tsuruo, T., Yamori, T., Naganuma, K., Tsukagoshi, S., and Sakurai, Y. (1983) Characterization of metastatic clones derived from a metastatic variant of mouse colon adenocarcinoma 26. Cancer Res. 43, 5437-5442
16. Yamori, T., Tsuruo, T., Naganuma, K., Tsukagoshi, S., and Sakurai, Y. (1984) Isolation and characterization of highly and rarely metastatic clones from murine colon adenocarcinoma. Invasion Metastasis 4, 84-97
17. Tsuruo, T., Watanabe, M., and Oh-hara, T. (1989) Stimulation of the growth of metastatic clones of mouse colon adenocarcinoma 26 in vitro by platelet-derived growth factor. Jpn. J. Cancer Res. 80, 136-140
18. r 44, 000 membrane protein as determined by monoclonal antibodies. Cancer Res. 48, 6411-6416
19. Tohgo, A., Tanaka, N, Ashida, S., and Ogawa, H. (1984) Platelet-aggregating activities of metastasizing tumor cells. II. Variety of the aggregation mechanisms. Invasion Metastasis 4, 134-145
20. r 41, 000 glycoprotein associated with thrombin-independent platelet aggregation in high metastatic variants of murine B16 melanoma. Cancer Res. 50, 6657-6662
21. Sugimoto, Y., Watanabe, M., Oh-hara, T., Sato, S., Isoe, T., and Tsuruo, T. (1991) Suppression of experimental lung colonization of a metastatic variant of murine colon adenocarcinoma 26 by a monoclonal antibody 8F11 inhibiting tumor cell-induced platelet aggregation. Cancer Res. 51, 921-925
22. Toyoshima, M., Nakajima, M., Yamori, T., and Tsuruo, T. (1995) Purification and characterization of the platelet-aggregating sialoglycoprotein gp44 expressed by highly metastatic variant cells of mouse colon adenocarcinoma 26. Cancer Res. 55, 767-773
23. Kato, Y., Fujita, N, Kunita, A., Sato, S., Kaneko, M., Osawa, M., and Tsuruo, T. (2003) Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors. J. Biol. Chem. 278, 51599-51605
24. Kaneko, M.K., Kato, Y., Kitano, T., and Osawa, M. (2006) Conservation of a platelet activating domain of Aggrus/podoplanin as a platelet aggregation-inducing factor. Gene 378, 52-57
25. Kaneko, M., Kato, Y., Kunita, A., Fujita, N, Tsuruo, T., and Osawa, M. (2004) Functional sialylated O-glycan to platelet aggregation on Aggrus (T1alpha/Podoplanin) molecules expressed in Chinese hamster ovary cells. J. Biol. Chem. 279, 38838-38843
26. Amano, K, Chiba, Y., Kasahara, Y., Kato, Y., Kaneko, M.K., Kuno, A., Ito, H., Kobayashi, K, Hirabayashi, J., Jigami, Y., and Narimatsu, H. (2008) Engineering of mucin-type human glycoproteins in yeast cells. Proc. Natl. Acad. Sci. USA. 105, 3232-3237
27. Kunita, A., Kashima, T.G, Morishita, Y., Fukayama, M., Kato, Y., Tsuruo, T., and Fujita, N. (2007) The platelet aggregation-inducing factor Aggrus/podoplanin promotes pulmonary metastasis. Am. J. Pathol. 170, 1337-1347
28. Schacht, V., Ramirez, M.I., Hong, Y.K., Hirakawa, S., Feng, D., Harvey, N, Williams, M., Dvorak, A.M., Dvorak, H.F., Oliver, G, and Detmar, M. (2003) T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 22, 3546-3556
29. Ramirez, M.I., Millien, G., Hinds, A., Cao, Y., Seldin, D.C., and Williams, M.C. (2003) T1alpha, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth. Dev. Biol. 256, 61-72
30. Uhrin, P., Zaujec, J., Breuss, J.M., Olcaydu, D., Chrenek, P., Stockinger, H., Fuertbauer, E., Moser, M., Haiko, P., Fassler, R., Alitalo, K., Binder, B.R., and Kerjaschki, D. (2010) Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood 115, 3997-4005
31. Ohizumi, I., Harada, N., Taniguchi, K., Tsutsumi, Y., Nakagawa, S., Kaiho, S., and Mayumi, T. (2000) Association of CD44 with OTS-8 in tumor vascular endothelial cells. Biochim. Biophys. Acta. 1497, 197-203
32. Nakazawa, Y., Sato, S., Naito, M., Kato, Y., Mishima, K., Arai, H., Tsuruo, T., and Fujita, N. (2008) Tetraspanin family member CD9 inhibits Aggrus/podo-planin-induced platelet aggregation and suppresses pulmonary metastasis. Blood 112, 1730-1739
33. Cueni, L.N. and Detmar, M. (2009) Galectin-8 interacts with podoplanin and modulates lymphatic endothelial cell functions. Exp. Cell Res. 315, 1715-1723
34. Kerjaschki, D., Regele, H.M., Moosberger, I., Nagy-Bojarski, K., Watschinger, B., Soleiman, A., Birner, P., Krieger, S., Hovorka, A., Silberhumer, G., Laakkonen, P., Petrova, T., Langer, B., and Raab, I. (2004) Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J. Am. Soc. Nephrol. 15, 603-612
35. Suzuki-Inoue, K, Kato, Y., Inoue, O., Kaneko, M.K., Mishima, K, Yatomi, Y., Yamazaki, Y., Narimatsu, H., and Ozaki, Y. (2007) Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J. Biol. Chem. 282, 25993-26001
36. Suzuki-Inoue, K, Fuller, GL., Garcia, A., Eble, J.A., Pohlmann, S., Inoue, O., Gartner, T.K., Hughan, S.C., Pearce, A.C., Laing, G.D., Theakston, R.D., Schweighoffer, E., Zitzmann, N, Morita, T., Tybulewicz, V.L., Ozaki, Y., and Watson, S.P. (2006) A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood 107, 542-549
37. Suzuki-Inoue, K. (2011) Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation. J. Biochem. 150, 127-132
38. Lowe, K.L., Navarro-Nunez, L., and Watson, S.P. (2012) Platelet CLEC-2 and podoplanin in cancer metastasis. Thromb. Res. 129, S30-S37
39. Nakazawa, Y., Takagi, S., Sato, S., Oh-hara, T., Koike, S., Takami, M., Arai, H., and Fujita, N. (2011) Prevention of hematogenous metastasis by neutralizing mice and its chimeric anti-Aggrus/podoplanin antibodies. Cancer Sci. 102, 2051-2057
40. Ogasawara, S., Kaneko, M.K., Price, J.E., and Kato, Y. (2008) Characterization of anti-podoplanin monoclonal antibodies: critical epitopes for neutralizing the interaction between podoplanin and CLEC-2. Hybridoma 27, 259-267
41. Kato, Y., Kaneko, M.K., Kunita, A., Ito, H., Kameyama, A., Ogasawara, S., Matsuura, N, Hasegawa, Y., Suzuki-Inoue, K, Inoue, O., Ozaki, Y., and Narimatsu, H. (2008) Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2. Cancer Sci. 99, 54-61
42. Hughes, CE., Pollitt, A.Y., Mori, J., Eble, J.A., Tomlinson, M.G, Hartwig, J.H., O'Callaghan, C.A., Futterer, K, and Watson, S.P. (2010) CLEC-2 activates Syk through dimerization. Blood 115, 2947-2955
43. Kawase, A., Ishii, G, Nagai, K, Ito, T., Nagano, T., Murata, Y., Hishida, T., Nishimura, M., Yoshida, J., Suzuki, K, and Ochiai, A. (2008) Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma. Int. J. Cancer 123, 1053-1059
44. Wicki, A., Lehembre, F., Wick, N, Hantusch, B., Kerjaschki, D., and Christofori, G (2006) Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskel-eton. Cancer Cell 9, 261-272
45. Durchdewald, M., Guinea-Viniegra, J., Haag, D., Riehl, A., Lichter, P., Hahn, M., Wagner, E.F., Angel, P., and Hess, J. (2008) Podoplanin is a novel fos target gene in skin carcinogenesis. Cancer Res. 68, 6877-6883
46. Shen, Y., Chen, C.S., Ichikawa, H., and Goldberg, GS. (2010) SRC induces podoplanin expression to promote cell migration. J. Biol. Chem. 285, 9649-9656
47. Martin-Villar, E., Megias, D., Castel, S., Yurrita, M.M., Vilaro, S., and Quintanilla, M. (2006) Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition. J. Cell Sci. 119, 4541-4553
48. Labelle, M., Begum, S., and Hynes, R.O. (2011) Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 20, 576-590
49. Hatakeyama, K, Kaneko, M.K., Kato, Y., Ishikawa, T., Nishihira, K, Tsujimoto, Y., Shibata, Y., Ozaki, Y., and Asada, Y. (2012) Podoplanin expression in advanced atherosclerotic lesions of human aortas. Thromb. Res. 129, e70-e76
50. Kerrigan, A.M., Navarro-Nunez, L., Pyz, E., Finney, B.A., Willment, J.A., Watson, S.P., and Brown, GD. (2012) Podoplanin-expressing inflammatory macrophages activate murine platelets via CLEC-2. J. Thromb. Haemost. 10, 484-486